[{"uuid": "f03e4a71-c86b-3e85-b57d-f9f61590e326", "title": "Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/dianthus-therapeutics-webcast-presentations-two-120000426.html", "providerPublishTime": 1738238400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/dAM_eMt8TpnD9GyVPtPvUg--~B/aD01ODA7dz0zMDY4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/54db327eecc6a0dd1bfaa2d727ce659a", "width": 3068, "height": 580, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Y504TzJpVlbVLbxjmZ7HBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/54db327eecc6a0dd1bfaa2d727ce659a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DNTH"]}, {"uuid": "5fb57661-b656-31c1-b6a1-70ce3bcfd0e0", "title": "Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/dianthus-therapeutics-webcast-presentation-43rd-120000700.html", "providerPublishTime": 1736337600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/dAM_eMt8TpnD9GyVPtPvUg--~B/aD01ODA7dz0zMDY4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/54db327eecc6a0dd1bfaa2d727ce659a", "width": 3068, "height": 580, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Y504TzJpVlbVLbxjmZ7HBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/54db327eecc6a0dd1bfaa2d727ce659a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DNTH"]}, {"uuid": "4db2c7a6-b921-355b-a0c6-246ed7d9f25b", "title": "TD Cowen Initiates Coverage on Dianthus Therapeutics With Buy Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/td-cowen-initiates-coverage-dianthus-123048111.html", "providerPublishTime": 1734697848, "type": "STORY"}, {"uuid": "7ffcffb2-94a6-3623-bf4f-236e60852198", "title": "Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Tops Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/dianthus-therapeutics-inc-dnth-reports-223510251.html", "providerPublishTime": 1731018910, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2", "width": 900, "height": 741, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fK_ZnUjpgS53xdJHns_S2A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "3e8713eb-5497-3ee8-80e8-cb124833a6b2", "title": "Dianthus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/dianthus-therapeutics-third-quarter-2024-130543172.html", "providerPublishTime": 1731243943, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 945, "height": 636, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/NamfX5LEtyScIu4YmRG2hg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DNTH"]}, {"uuid": "7b7609a3-52a7-3cf0-b87b-823229f826a3", "title": "Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/dianthus-therapeutics-highlights-recent-business-210100982.html", "providerPublishTime": 1731013260, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/dAM_eMt8TpnD9GyVPtPvUg--~B/aD01ODA7dz0zMDY4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/54db327eecc6a0dd1bfaa2d727ce659a", "width": 3068, "height": 580, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Y504TzJpVlbVLbxjmZ7HBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/54db327eecc6a0dd1bfaa2d727ce659a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DNTH"]}, {"uuid": "48adb490-ee56-340b-81fb-0bb64fcb1830", "title": "Gilead Sciences (GILD) Q3 Earnings and Revenues Surpass Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/gilead-sciences-gild-q3-earnings-221514946.html", "providerPublishTime": 1730931314, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/F3nzpi36wi9juoO_v9PrEA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/aDH3K02ilxL.wIxqZgf1dw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/2a50596f066181e48e4ae0ad6be00462", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GILD"]}]